|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||35.93 - 36.59|
|52 Week Range||33.46 - 44.14|
|Beta (5Y Monthly)||0.90|
|PE Ratio (TTM)||23.68|
|Forward Dividend & Yield||0.78 (2.01%)|
|Ex-Dividend Date||Oct 29, 2021|
|1y Target Est||45.00|
UNVR vs. AKZOY: Which Stock Is the Better Value Option?
European stocks struggle as a big batch of earnings roll out and with more worrying inflation signals, this time out of Germany.
Nouryon BV, the former chemicals arm of AkzoNobel, said on Friday it had filed an application with the U.S. Securities and Exchange Commission (SEC) to seek an initial public offering (IPO) of shares. Akzo sold Nouryon to The Carlyle Group in 2018 in a deal then worth 10.1 billion euros ($12 billion). Nouryon had adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of $970 million in 2020 on sales of $4.2 billion, a company fact sheet published on its website said.